Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
77 GBX | -1.28% | -0.65% | +18.46% |
05-23 | JPMorgan raises Unilever to 'overweight' | AN |
05-23 | Transcript : Tharisa plc, H1 2024 Earnings Call, May 23, 2024 |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company shows low valuation levels, with an enterprise value at 8.05 times its sales.
- The company appears to be poorly valued given its net asset value.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past twelve months, EPS forecast has been revised upwards.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- Most analysts recommend that the stock should be sold or reduced.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Non-Gold Precious Metals & Minerals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+18.46% | 314M | - | ||
-39.00% | 8.54B | A- | ||
-21.39% | 2.38B | A- | ||
+9.30% | 266M | C- | ||
-16.64% | 209M | - | ||
+53.33% | 176M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- THA Stock
- THS Stock
- Ratings Tharisa plc